Randomized Controlled Trial
doi: 10.1097/01.aids.0000238418.43937.3b.
Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients
Affiliations
- PMID: 16868453
- DOI: 10.1097/01.aids.0000238418.43937.3b
Item in Clipboard
Randomized Controlled Trial
Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients
AIDS.
.
Abstract
We tested the security and efficacy of ezetimibe in the treatment of HIV-associated dyslipemia. Twenty HIV-infected patients were randomly assigned to receive ezetimibe 10 mg/day or fluvastatin 80 mg/day. Patients receiving ezetimibe experienced a statistically significant (P = 0.003) 20% reduction in the concentration of LDL-cholesterol, similar to that observed with fluvastatin (24%, P between groups 0.70). We concluded that ezetimibe monotherapy effectively decreases LDL-cholesterol in HIV-infected patients.
Similar articles
-
Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013. Clin Ther. 2008. PMID: 18343245 Clinical Trial.
-
The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.Curr Med Res Opin. 2005 Aug;21(8):1171-9. doi: 10.1185/030079905X46386. Curr Med Res Opin. 2005. PMID: 16083526 Clinical Trial.
-
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.Eur J Clin Invest. 2010 Mar;40(3):187-94. doi: 10.1111/j.1365-2362.2009.02249.x. Epub 2010 Jan 7. Eur J Clin Invest. 2010. PMID: 20067513 Clinical Trial.
-
Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.Endocrinol Metab Clin North Am. 2009 Mar;38(1):79-97. doi: 10.1016/j.ecl.2008.11.007. Endocrinol Metab Clin North Am. 2009. PMID: 19217513 Review.
-
Statin and ezetimibe combination therapy in cardiovascular disease.Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):183-8. doi: 10.1097/MED.0b013e3283295297. Curr Opin Endocrinol Diabetes Obes. 2009. PMID: 19262375 Review.
Cited by
-
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.Int J Vasc Med. 2012;2012:201027. doi: 10.1155/2012/201027. Epub 2011 Aug 22. Int J Vasc Med. 2012. PMID: 21876813 Free PMC article.
-
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients.Lipids Health Dis. 2015 Jun 19;14:57. doi: 10.1186/s12944-015-0054-x. Lipids Health Dis. 2015. PMID: 26087958 Free PMC article. Clinical Trial.
-
Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient.NDT Plus. 2008 Jun;1(3):157-61. doi: 10.1093/ndtplus/sfn012. NDT Plus. 2008. PMID: 25983864 Free PMC article. No abstract available.
-
Treatment of dyslipidemia in HIV.Curr Atheroscler Rep. 2015 Apr;17(4):493. doi: 10.1007/s11883-015-0493-x. Curr Atheroscler Rep. 2015. PMID: 25702057 Review.
-
Approach to the human immunodeficiency virus-infected patient with lipodystrophy.J Clin Endocrinol Metab. 2008 Aug;93(8):2937-45. doi: 10.1210/jc.2008-1019. J Clin Endocrinol Metab. 2008. PMID: 18685115 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
